Engy › Who's who in longevity › Sofiya Milman
At a glance
- American physician-scientist at the Albert Einstein College of Medicine in New York, part of its Institute for Aging Research.
- Studies people who live exceptionally long, healthy lives, and their children, to find biological mechanisms that delay disease. She has published on HDL cholesterol, the growth hormone/IGF-1 axis and rare genetic variants in these families.
- In 2026 she published a multi-cohort analysis in JAMA Network Open: children of parents with exceptional longevity developed disease and died later.
- Contributes to the SuperAger Initiative to map the genetics of exceptional longevity, and to research on ‘super movers’ and cognitive ageing.
- Also works on digital research platforms that make it easier for people over 65 to take part in studies.
- Relevant because it helps clarify what is inherited and what we can influence ourselves — and why drugs that target these pathways are being studied.
Recent
- Study Exceptional Parental Longevity and Onset of Morbidity and Mortality Across Cohorts
- Study Identification of functional rare coding variants in IGF-1 gene in humans with exceptional longevity
- Study Tailored Approach to Designing a Digital Research Platform for Adults Aged 95 and Older: SuperAgers Family Study